• Protocols

• ARST2032

  OPEN TO ACCRUAL

  Phase 3 study for Newly Dx VLR and LR Fusion Negative RST
  
  

• UW18143

  OPEN TO ACCRUAL

  Conditioning SCID Infants Diagnosed Early (CSIDE)
  
  

• UW23111

  OPEN TO ACCRUAL

  POETIC PARPAML, Phase 1 Relapsed Pediatric AML using Talazoparib